Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization.

Details for Australian Patent Application No. 2004273686 (hide)

Owner INSERM (Institut National de la Sante et de la Recherche Medicale) Institut Pasteur Centre National de la Recherche Scientifique

Inventors Veron, Michel; Traincard, Francois; Courtois, Gilles; Baleux, Francoise; Yamaoka, Shoji; Israel, Alain; Agou, Fabrice; Coic, Yves-Marie

Agent Davies Collison Cave

Pub. Number AU-B-2004273686

PCT Pub. Number WO2005/027959

Priority 60/505,161 24.09.03 US; 60/530,418 18.12.03 US

Filing date 24 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 3 March 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/027959 Priority application(s): WO2005/027959

6 August 2009 Amendment Made

  The nature of the amendment is: Add the name of the co-inventor to read Coic, Yves-Marie

3 March 2011 Application Accepted

  Published as AU-B-2004273686

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273692-Reverse flow spin-cleaning liquid filters

2004273672-Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate